IL6 and metabolic dysfunction-associated steatotic liver disease: Accordingly, patients with NAFLD have been reported to have elevated levels of inflammatory biomarkers, including high-sensitivity C-reactive protein (CRP) [9], tumor necrosis factor-α (TNF-α) [10], and interleukin-6 (IL-6) [11].